AstraZeneca PLC Submits sNDA for SEROQUEL XR(TM) for the Treatment …
Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric disorders . … (1,2) The disorder comes on gradually and can begin across the life cycle. GAD rarely occurs alone and is often accompanied by other anxiety disorders , depression , or substance abuse. Genetic factors are also thought to be involved
View original post here:
AstraZeneca PLC Submits sNDA for SEROQUEL XR(TM) for the Treatment …
Popularity: unranked [?]